Scientis has announced the results of the first head-to-head comparisons of cysteamine 5% cream (CYS) in different clinical studies, versus the gold standard modified Kligman’s...
A novel formulation of botulinum toxin type A substantially improved the appearance of dynamic forehead lines while garnering favorable patient satisfaction scores in an...
A study from global pharmaceutical company Galderma has indicated that 95% of patients treated with Azzalure abobotulinum toxin A achieved high levels...
Foamix Pharmaceuticals Ltd.’s FMX103 1.5% Topical Minocycline Foam for rosacea performed well in an integrated efficacy analysis of two pivotal Phase 3 clinical trials...
Dermata Therapeutics, LLC completed enrollment of patients in its Phase 2b clinical trial evaluating the safety, tolerability and efficacy of DMT310 in moderate...
Dr. Michael Omidi, M.D., F.A.C.S., is a double-board certified plastic surgeon practicing in Beverly Hills and greater Los Angeles specializing in cosmetic surgery....